Daniel Janney - Net Worth and Insider Trading
Daniel Janney Net Worth
The estimated net worth of Daniel Janney is at least $34 Million dollars as of 2024-03-28. Daniel Janney is the Director of Krystal Biotech Inc and owns about 107,362 shares of Krystal Biotech Inc (KRYS) stock worth over $19 Million. Daniel Janney is the Director, 10% Owner of Allakos Inc and owns about 9,050,493 shares of Allakos Inc (ALLK) stock worth over $12 Million. Daniel Janney is also the Director of Esperion Therapeutics Inc and owns about 1,366,987 shares of Esperion Therapeutics Inc (ESPR) stock worth over $4 Million. Besides these, Daniel Janney also holds Viveve Medical Inc (VIVE) . Details can be seen in Daniel Janney's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Janney has not made any transactions after 2023-06-09 and currently still holds the listed stock(s).
Transaction Summary of Daniel Janney
Daniel Janney Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Janney owns 21 companies in total, including Krystal Biotech Inc () , Esperion Therapeutics Inc () , and Allakos Inc () among others .
Click here to see the complete history of Daniel Janney’s form 4 insider trades.
Insider Ownership Summary of Daniel Janney
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Krystal Biotech Inc | 2023-06-09 | director | |
Esperion Therapeutics Inc | 2017-03-21 | director | |
Allakos Inc | 2022-09-21 | director | |
Sutro Biopharma Inc | 2018-09-26 | director & 10 percent owner | |
Viveve Medical Inc | 2017-03-17 | director & 10 percent owner | |
Evofem Biosciences Inc | 2014-11-19 | director & 10 percent owner | |
ZS Pharma Inc | 2015-06-05 | 10 percent owner | |
aTyr Pharma Inc | 2015-05-06 | 10 percent owner | |
KalVista Pharmaceuticals Inc | 2015-04-08 | 10 percent owner | |
Trevena Inc | 2014-01-30 | 10 percent owner | |
Applied Genetic Technologies Corp | 2014-03-26 | 10 percent owner | |
Immune Design Corp | 2014-07-29 | 10 percent owner | |
Aerie Pharmaceuticals Inc | 2013-10-25 | 10 percent owner | |
Ellie Mae Inc | 2011-04-20 | 10 percent owner | |
Talphera Inc | 2011-02-10 | 10 percent owner | |
Raptor Pharmaceutical Corp | 2009-09-03 | other: No longer 10% owner | |
NeurogesX Inc | 2007-05-07 | 10 percent owner | |
Dynavax Technologies Corp | 2004-02-11 | director | |
Cutera Inc | 2004-03-31 | 10 percent owner | |
Avadel Pharmaceuticals PLC | 2003-08-27 | 10 percent owner | |
Tyra Biosciences Inc | 2021-09-14 | 10 percent owner |
Daniel Janney Latest Holdings Summary
Daniel Janney currently owns a total of 4 stocks. Among these stocks, Daniel Janney owns 107,362 shares of Krystal Biotech Inc (KRYS) as of June 9, 2023, with a value of $19 Million and a weighting of 55.63%. Daniel Janney owns 9,050,493 shares of Allakos Inc (ALLK) as of September 21, 2022, with a value of $12 Million and a weighting of 33.91%. Daniel Janney also owns 1,366,987 shares of Esperion Therapeutics Inc (ESPR) as of March 21, 2017, with a value of $4 Million and a weighting of 10.46%. The other 1 stocks Viveve Medical Inc (VIVE) have a combined weighting of 0% among all his current holdings.
Latest Holdings of Daniel Janney
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRYS | Krystal Biotech Inc | 2023-06-09 | 107,362 | 177.04 | 19,007,368 |
ALLK | Allakos Inc | 2022-09-21 | 9,050,493 | 1.28 | 11,584,631 |
ESPR | Esperion Therapeutics Inc | 2017-03-21 | 1,366,987 | 2.62 | 3,574,671 |
VIVE | Viveve Medical Inc | 2017-03-17 | 1,385 | 0.00 | 0 |
Holding Weightings of Daniel Janney
Daniel Janney Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel Janney has made a total of 6 transactions in Krystal Biotech Inc (KRYS) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Krystal Biotech Inc is the sale of 50,000 shares on June 9, 2023, which brought Daniel Janney around $6 Million.
According to the SEC Form 4 filings, Daniel Janney has made a total of 5 transactions in Allakos Inc (ALLK) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Allakos Inc is the acquisition of 475,000 shares on September 21, 2022, which cost Daniel Janney around $2 Million.
According to the SEC Form 4 filings, Daniel Janney has made a total of 0 transactions in Esperion Therapeutics Inc (ESPR) over the past 5 years. The most-recent trade in Esperion Therapeutics Inc is the sale of 350,000 shares on March 21, 2017, which brought Daniel Janney around $16 Million.
More details on Daniel Janney's insider transactions can be found in the Insider Trading History of Daniel Janney table.Insider Trading History of Daniel Janney
- 1
Daniel Janney Trading Performance
GuruFocus tracks the stock performance after each of Daniel Janney's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Daniel Janney is 40.48%. GuruFocus also compares Daniel Janney's trading performance to market benchmark return within the same time period. The performance of stocks bought by Daniel Janney within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Daniel Janney's insider trading performs compared to the benchmark.
Performance of Daniel Janney
Average Relative Return
-2.85%
Outperforming Transactions
33%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | 18.35 | 40.48 | 61.69 | -2.85 | 46.2 | 4.46 |
Relative Return to S&P 500(%) | 15.93 | 37.29 | 56.2 | -16.23 | 37.37 | -4.99 |
Daniel Janney Ownership Network
Ownership Network List of Daniel Janney
Ownership Network Relation of Daniel Janney
Daniel Janney Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
Daniel Janney is the director of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , director & 10 percent owner & Chief Operating Officer Suma Krishnan , and Chief Accounting Officer Kathryn Romano .
Krystal Biotech Inc () Insider Trades Summary
Over the past 18 months, Daniel Janney made 4 insider transaction in Krystal Biotech Inc () with a net sale of 125,000. Other recent insider transactions involving Krystal Biotech Inc () include a net sale of 350,000 shares made by Krish S Krishnan , a net sale of 350,000 shares made by Suma Krishnan , and a net sale of 76,515 shares made by Kathryn Romano .
In summary, during the past 3 months, insiders sold 123,087 shares of Krystal Biotech Inc () in total and bought 0 shares, with a net sale of 123,087 shares. During the past 18 months, 954,015 shares of Krystal Biotech Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 954,015 shares.
Krystal Biotech Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
Daniel Janney Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Janney. You might contact Daniel Janney via mailing address: Po Box 7414, Jackson Wy 83002.